Willis Towers Watson stock price target raised to $373 by Evercore ISI

Published 31/07/2025, 21:02
Willis Towers Watson stock price target raised to $373 by Evercore ISI

Investing.com - Evercore ISI has raised its price target on Willis Towers Watson (NASDAQ:WTW), a $31.3 billion market cap insurance broker, to $373.00 from $364.00 while maintaining an Outperform rating on the stock. According to InvestingPro data, analysts maintain a bullish consensus on WTW, with price targets ranging from $305 to $408.

The firm cited a "better quarter" as the basis for increasing its earnings per share estimates, reflecting slightly improved margins and Health growth going forward, as well as less drag from the Reinsurance buildout in the second half than previously estimated.

Evercore ISI noted the durability of WTW’s Health, Wealth and Career business, which represents approximately 60% of total revenue, along with a strong pipeline and reduced uncertainty as positive factors for the second half of the year.

The firm believes Willis Towers Watson still has "re-rating potential" into the back half of the year as organic growth remains consistent and free cash flow improves.

Evercore ISI suggested that recent drawdowns in broker stocks this week due to "idiosyncrasies at other brokers" have created interesting buying opportunities, particularly for Willis Towers Watson, AON and AJG.

In other recent news, Willis Towers Watson reported its second-quarter financial results, surpassing analyst expectations. The company achieved adjusted earnings of $2.86 per share, which was above the anticipated $2.63 per share. Additionally, revenue reached $2.3 billion, exceeding the consensus estimate of $2.23 billion. Despite the sale of its TRANZACT business, the company managed to deliver a 5% organic revenue growth, although overall reported revenue remained flat year-over-year. These developments highlight the company’s strong performance in the face of challenges. Analyst firms have noted these results, which may influence their future assessments. Investors are closely watching these updates to gauge the company’s financial health. These recent developments are pivotal for stakeholders.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.